Austin Dulak

Title: Austin Dulak: Innovator in Cancer Treatment

Introduction

Austin Dulak is a prominent inventor based in Reading, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work in antibody compositions. With a total of 3 patents to his name, Dulak is recognized for his dedication to advancing medical science.

Latest Patents

Dulak's latest patents include groundbreaking inventions such as "Anti-CD39 antibody compositions and methods," which provide anti-CD39 antibody compositions and their use in treating cancer. Another notable patent is "Antibodies that bind CD39 and uses thereof," which relates to anti-CD39 antibodies and their applications in cancer treatment. These inventions highlight his commitment to developing effective therapies for patients.

Career Highlights

Austin Dulak is currently employed at Surface Oncology, Inc., where he continues to push the boundaries of cancer research. His work at this innovative company allows him to collaborate with other experts in the field and contribute to the development of new treatment options.

Collaborations

Dulak has worked alongside talented colleagues such as Scott C. Chappel and Andrew Lake. Their combined expertise fosters a collaborative environment that enhances the potential for groundbreaking discoveries in cancer treatment.

Conclusion

Austin Dulak is a dedicated inventor whose work in antibody compositions is paving the way for new cancer therapies. His contributions to the field are invaluable, and his ongoing research promises to make a significant impact on patient care.